We recently published a list of 10 Micro-Cap Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where biote Corp. (NASDAQ:BTMD) stands against other micro-cap stocks insiders were buying in Q1 2025.

The White House announced Tuesday that Trump’s tariffs would take effect immediately after being unveiled on Wednesday. In anticipation of these “reciprocal tariffs,” which will apply to all countries, the stock market reacted. By Tuesday morning, the broader market index and Nasdaq Composite dropped by about 0.2%, while blue-chip companies lost 0.06%.

Amid ongoing market uncertainty, insider trading often comes under the spotlight. Executive stock purchases can signal optimism, but sales may reflect personal financial decisions or a need to diversify investments. To maintain transparency, executives typically follow pre-arranged strategies, like 10b5-1 plans. While insider trading can offer valuable information, it’s important to evaluate it in the broader context of the company’s financial stability and current market trends.

Our Methodology

Today, we’re focusing on stocks with micro market capitalizations that have seen significant insider buying in the first quarter of the year. Using Insider Monkey’s insider trading screener, we identified companies with market caps under $250 million where at least three insiders purchased shares in the past three months. From this list, we ranked the top 10 stocks with the highest number of insiders making purchases. Stocks that have been recently covered were excluded from our analysis.

Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

With each stock, we note the number of insiders who acquired shares in the first quarter and market capitalizations.biote Corp. (BTMD): Insider Were Buying In Q1 2025

A Biote-certified practitioner examining a patient's blood sample under a microscope.

biote Corp. (NASDAQ:BTMD)

Number of insiders buying: 5

Market Capitalization: $192.84 million

Biote specializes in hormone optimization, offering training and certification for physicians and nurse practitioners in bioidentical hormone replacement therapy. It ranks fifth among the 10 micro-cap stocks insiders were buying in Q1 2025.

The Irving, Texas-based company provides a comprehensive practice-building platform, including education, practice management software, inventory tools, and marketing support. Biote also sells dietary supplements and sterile pellet insertion kits for hormone therapy.

Story Continues

In March, five insiders, including the company’s CEO, acquired a total of $2.79 million worth of biote shares at an average price of $3.75 per share. Currently, the stock trades at $3.63 per share, having dropped 41.26% year-to-date and 37.09% over the past 12 months.

For the full year 2024, biote disclosed revenue of $197.2 million, up 6.4% year-over-year. The increase was primarily driven by growth in procedure revenue. Net income attributable to biote stockholders amounted to $3.16 million, compared to $3.32 million in 2023. Gross profit margin for 2024 was 70.5% compared to 68.8% for 2023. The increase in gross profit margin was primarily due to the vertical integration of its 503B manufacturing facility and effective cost management. Adjusted EBITDA for 2024 was $58.2 million, with an adjusted EBITDA margin of 29.5%, compared to adjusted EBITDA of $55.3 million, with an adjusted EBITDA margin of 29.8% for 2023.

The consensus rating on biote stock from six analysts is a “Strong Buy” with a price target of $7.36 per share, reports TipRanks. The average price target suggests a 102.75% upside from the latest price.

Overall, BTMD ranks 5th on our list of micro-cap stocks insiders were buying in Q1 2025. While we acknowledge the potential of BTMD our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than BTMD but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.

View Comments